Close
Nordic 9Nordic 9

Walden Catalyst Ventures (investor - Venture Capital)

United States waldencatalyst.com
See something wrong or missing? Let us know
Offices:San Francisco

Walden Catalyst Ventures is an American investment company founded by Lip-Bu Tan and Young Sohn.

Average round investment:63.85M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)2022 (1)
Portfolio companies: Switzerland ANYboticsNetherlands Nearfield InstrumentsUnited Kingdom Peptone
Mostly invests in: Switzerland Switzerland (2) Manufacturing (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Walden Catalyst Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Walden Catalyst Ventures

Name Criteria
United States Allen & Company
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Flexstone Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Robotics, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Hercules Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Venture Science
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fearless Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States National Resilience
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Concord Health Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States HealthQuest Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Monograph Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top